Logo of Almoosa Health Group
Almoosa Health Group issued today, Nov. 27, the prospectus for offering 13.29 million shares, or 30% of the company’s post-IPO share capital (37.97% of pre-IPO capital), on the Saudi Exchange (Tadawul) for a nominal value of SAR 10 per share.
The company intends to offer 13.29 million shares, representing 30% of post-IPO capital (37.97% of pre-IPO capital), at a nominal value of SAR 10 per share.
The period of registering requests and book building will run for five days from Dec. 4-10. Subscription by retail investors will be from Dec. 23-24, 2024.
In September, the Capital Market Authority (CMA) approved the company's application to float its shares on the main market.
Almoosa Health started its operations in 1994 as a branch of Abdulaziz Abdullah Abdulwahab Al-Moosa Trading Establishment under the name "Al-Mousa Specialist Hospital, Al-Ahsa".
The company operates primarily in the healthcare sector, providing integrated healthcare services including primary care, critical care and rehabilitation services at Al-Moosa Specialist Hospital (Al-Ahsa) and Al-Moosa Rehabilitation Hospital, Al-Ahsa. It also provides sucondary services to this sector such as pharmaceutical services, home health care services and telemedicine services.
|
Company Profile |
|
|
Company |
Almoosa Health Group |
|
Market |
Tadawul |
|
Core Activities |
Healthcare |
|
Pre-IPO Capital |
SAR 350 mln |
|
Capital after IPO |
SAR 443.04 mln |
|
Number of Shares |
35 mln |
|
Number of shares after IPO |
44.30 mln |
|
Share Par Value |
SAR 10/share |
|
IPO Summary |
|
|
Issue Percentage |
30% after IPO |
|
Number of Shares Offered |
13.29 mln shares (37.97% of pre-IPO shares) |
|
Qualified Subscribers |
Institutions - individuals |
|
IPO Minimum Limit for Retail Investors |
10 shares |
|
IPO Minimum Limit for Institutional Investors |
100,000 shares |
|
Maximum Limit for Retail Investors |
250,000 shares |
|
IPO Maximum Limit for Institutional Investors |
2.26 mln |
|
Institutional Subscription & Book-Building |
From Dec. 4 to 10, 2024 |
|
Retail Offering |
From Dec. 24- 25, 2024 |
|
Final Allocation |
Dec. 29, 2024 |
|
Refund (if any) |
Jan. 2, 2025 |
|
Additional Information |
|
|
Financial Advisor and Lead Manager |
Saudi Fransi Capital |
|
Institutional Bookrunners & Underwriters
|
EFG Hermes Saudi Arabia, Saudi Fransi Capital |
|
Receiving banks |
SNB Capital, SAB Invest, Al Rajhi Capital, Saudi Fransi Capital, Alinma Investment, Riyad Capital, AlJazira Capital, Alistithmar Capital, Albilad Capital, ANB Capital, Derayah Financial, Yaqeen Capital, Alkhabeer Capital, Sahm Capital |
|
Major Shareholders |
||||
|
Shareholders |
Before IPO |
After IPO |
||
|
Number of Shares (mln shares) |
Ownership (%) |
Number of Shares (mln shares) |
Ownership (%) |
|
|
Abdulaziz bin Abdullah Al-Moosa Investment Co. |
33.25 |
95.00% |
29.13 |
65.75% |
|
Abdulaziz Abdullah Al-Moosa Charitable Co. |
1.75 |
5.00% |
1.75 |
3.95% |
|
Public |
-- |
-- |
13.29 |
30.00% |
|
Total |
35.00 |
100% |
44.30 |
100% |
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}